PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 91 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q2 2014. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $70,000 | +45.8% | 113,208 | +5.1% | 0.00% | – |
| Q2 2016 | $48,000 | -50.5% | 107,686 | +17.0% | 0.00% | – |
| Q1 2016 | $97,000 | +2.1% | 92,009 | +186.8% | 0.00% | – |
| Q4 2015 | $95,000 | +9400.0% | 32,078 | +6710.6% | 0.00% | – |
| Q3 2015 | $1,000 | -94.1% | 471 | -83.4% | 0.00% | – |
| Q2 2015 | $17,000 | +1600.0% | 2,839 | +2710.9% | 0.00% | – |
| Q1 2015 | $1,000 | -98.6% | 101 | -98.7% | 0.00% | – |
| Q4 2014 | $74,000 | +1750.0% | 7,926 | +1565.1% | 0.00% | – |
| Q3 2014 | $4,000 | -94.0% | 476 | -93.6% | 0.00% | – |
| Q2 2014 | $67,000 | – | 7,480 | +83011.1% | 0.00% | – |
| Q1 2014 | $0 | – | 9 | -94.4% | 0.00% | – |
| Q4 2013 | $0 | -100.0% | 162 | -67.3% | 0.00% | – |
| Q3 2013 | $1,000 | -97.3% | 495 | -95.1% | 0.00% | – |
| Q2 2013 | $37,000 | – | 10,170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|